Postoperative tiotropium bromide and salmeterol, versus no bronchodilator therapy, in patients with chronic obstructive pulmonary disease and lung cancer undergoing lobectomy.

Trial Profile

Postoperative tiotropium bromide and salmeterol, versus no bronchodilator therapy, in patients with chronic obstructive pulmonary disease and lung cancer undergoing lobectomy.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 18 Dec 2007

At a glance

  • Drugs Salmeterol (Primary) ; Tiotropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top